199 results on '"Hullsiek, Katherine Huppler"'
Search Results
2. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort
3. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda
4. Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials
5. Hydroxychloroquine for treatment of non‐hospitalized adults with COVID ‐19: A meta‐analysis of individual participant data of randomized trials
6. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
7. Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial
8. Response to Bandera et al
9. Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection
10. Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected With HIV and Hepatitis Viruses
11. Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure
12. Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters
13. Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
14. A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV-Infected Adults
15. Epidemiology of Hepatitis B Virus Infection in a US Cohort of HIV-Infected Individuals during the Past 20 Years
16. High-Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection
17. Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes
18. Mild-to-Moderate Symptoms during the First Year of Antiretroviral Therapy Worsen Quality of Life in HIV-Infected Individuals
19. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality.
20. Considerations for Endpoint Selection When Designing HIV Clinical Trials
21. A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis
22. Additional file 1 of Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda
23. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
24. Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: Final Results of the CPCRA 064 study
25. Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic
26. Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus
27. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. (HIV/AIDS)
28. The Timing of Hepatitis B Virus (HBV) Immunization Relative to Human Immunodeficiency Virus (HIV) Diagnosis and the Risk of HBV Infection Following HIV Diagnosis
29. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
30. Is Kaposiʼs sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?
31. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence
32. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals
33. A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults
34. Cutaneous Malignancies Among HIV-Infected Persons
35. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study
36. Virologic, Immunologic, Clinical, Safety, and Resistance Outcomes from a Long-Term Comparison of Efavirenz-Based Versus Nevirapine-Based Antiretroviral Regimens as Initial Therapy in HIV-1-Infected Persons
37. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance
38. The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies
39. Propensity score modeling strategies for the causal analysis of observational data
40. Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.
41. Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic.
42. Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure
43. Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016
44. Relationship between Minority NNRTI Resistance Mutations, Adherence, and the Risk of Virologic Failure
45. IL-6 and D-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection
46. Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons.
47. Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
48. Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure
49. Considerations for Endpoint Selection When Designing HIV Clinical Trials
50. Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.